stars 1 stars 2 stars 3

Cellgen is developing a bio-fluid based molecular diagnostic that will serve as a therapeutic guidance platform for cancer patients. The platform incorporates machine learning to deliver intelligent, quantitative and actionable results to oncologists in under 5 hours. Designed to detect all DNA and RNAs, Cellgen’s platform features a proprietary on-chip enrichment and detection workflow perfectly suited to be installed as the premier Companion Diagnostic testing system within leading oncology clinics. Running on Cellgen's proprietary platform, each disposable assay will yield inclusion / exclusion data, while also leveraging proprietary machine learning algorithms to intelligently monitor and predict therapeutic response. This information will help inform patients, physicians, and others on how best to simplify and optimize life-saving clinical protocols.

Cellgen Diagnostics Questions

The Cellgen Diagnostics annual revenue was $600000 in 2026.

Cellgen Diagnostics is based in San Diego, California.

The NAICS codes for Cellgen Diagnostics are [62, 621].

The SIC codes for Cellgen Diagnostics are [807, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users